BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeung JHY, Palpagama TH, Wood OWG, Turner C, Waldvogel HJ, Faull RLM, Kwakowsky A. EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer's Disease. Front Cell Neurosci 2021;15:702824. [PMID: 34588956 DOI: 10.3389/fncel.2021.702824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontana IC, Souza DG, Souza DO, Gee A, Zimmer ER, Bongarzone S. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases. J Med Chem 2023;66:2330-46. [PMID: 36787643 DOI: 10.1021/acs.jmedchem.2c01572] [Reference Citation Analysis]
2 García-gaytán AC, Hernández-abrego A, Díaz-muñoz M, Méndez I. Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1029210] [Reference Citation Analysis]
3 Wood OWG, Yeung JHY, Faull RLM, Kwakowsky A. EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review. Front Neurosci 2022;16:952096. [DOI: 10.3389/fnins.2022.952096] [Reference Citation Analysis]
4 Andersen JV, Schousboe A, Verkhratsky A. Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate/GABA-glutamine cycle. Prog Neurobiol 2022;:102331. [PMID: 35872221 DOI: 10.1016/j.pneurobio.2022.102331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]